Alnylam Act - No Charge, Third Party Genetic Testing \u0026 Counseling

(1:24)

Alnylam Pharma and the Science of RNAi

(1:5)

hATTR amyloidosis: Explore Genetic Testing

(2:4)

hATTR amyloidosis: The Importance of Genetic Testing

(2:38)

The Alnylym Act Program for AHP Patients

(7:9)

Who We Are: Alnylam's Core Values

(2:39)

Dr. Pushkal Garg Discusses Alnylam's Rare Disease Day Initiatives

(2:15)

Rosaline, living with Hereditary ATTR (hATTR) amyloidosis

(4:7)

Cerebral Amyloid Angiopathy (CAA) Webinar, November 23, 2024

(2:18)

One family’s journey with hereditary TTR amyloidosis: Dan and Diana

(6:40)

UPDATE ON PLANNED CLINICAL TRIALS - EHDN2024 DAY 2

(56:35)

Expert Insights Into Amyloidosis: Diagnosing AL and ATTR Cardiac Amyloidosis

(13:28)

hATTR amyloidosis: The Family Dynamic

(3:18)

ICER Midwest CEPAC Public Meeting on Transthyretin Amyloid Cardiomyopathy: Evidence Presentation

(1:20:19)

Treatments for Transthyretin Amyloidosis (ATTR)

(2:5:57)

Cramer: This biotech stock could be worth over $100 billion on an FDA approval

(5:19)

John, living with Hereditary ATTR (hATTR) amyloidosis

(3:54)

Alnylam Pharmaceuticals sponsors CPR webinar, empowering Boston companies with life-saving skills

(24:58)

Alnylam Launches Hereditary ATTR (hATTR) Amyloidosis Campaign to Help Shorten Time to Diagnosis...

(1:38)

From Possibility to Patients: The Scientific Odyssey - The RNAi Boom

(2:43)

The Coyle Family Story - Living with Hereditary ATTR (hATTR) amyloidosis

(3:53)

From Possibility to Patients: The Scientific Odyssey - The Slope of Enlightenment

(3:32)

Alnylam Overview and it's Focus on RNA Interference

(3:12)

Ep. 187 - Alnylam-Roche; Plus: Insights on the IRA, FTC

(24:56)

Dr. Yvonne Greenstreet, CEO, Alnylam

(2:2)

Ep. 144 - Alnylam's IRA Pause, Plus Argenx \u0026 Accumulus

(24:45)